CIMED, one of Brazil’s largest and fastest-growing companies in the pharmaceutical, consumer health and beauty and personal care sectors, has secured a landmark investment from GIC, the Singaporean sovereign wealth fund. This strategic minority investment represents the largest foreign private equity investment in these sectors over the past decade.

Announced on March 17, this transaction is a testament to CIMED’s robust positioning within the Brazilian pharma and consumer health markets. As a national leader with a distinguished portfolio of iconic brands such as Carmed, Lavitan, Xô Inseto, K-MED and Cimegripe, CIMED is at the forefront of innovation and growth. The company is actively expanding into new markets and categories, including baby care, oral care and aesthetics, with brands like João e Maria, Carmed and Milimetric.

The transaction not only highlights the attractiveness of the Brazilian pharma and consumer health markets, but also underscores CIMED’s role as a major player in attracting strategic long-term capital from leading global investors. With this investment, CIMED is poised to make a substantial impact on the overall dynamics in pharma and consumer health, reinforcing its leadership and commitment to growth and innovation.

CIMED’s mission to provide accessible and high-quality goods to all Brazilians, regardless of socioeconomic background, is a cornerstone of its strategy and the investment from GIC will enable CIMED to further its mission to ensure that more Brazilians have access to essential health and personal care products. The company’s commitment to inclusivity and accessibility bridges the gap in healthcare availability across the country.

Additionally, CIMED is changing the way small retailers interact with pharmaceutical producers by introducing new technologies and fostering connections with independent drug stores across Brazil. Independent drugstore retailers in Brazil account for more than 80 percent of the points of sale, and yet there is ample room for technological and financial development. CIMED’s approach empowers these retailers, providing them with the tools and support needed to thrive in a competitive market. By leveraging technology and innovation, CIMED is enhancing the distribution network, ensuring that even the most remote areas have access to its products.

“We are proud to have a strategic partner with a global connection like GIC by our side to accelerate our growth journey,” said João Adibe Marques, CEO of CIMED. The investment by GIC is a key component of CIMED’s ambitious growth strategy, “CIMED’s New Era,” which aims to triple the company’s revenue over the next five years through innovation, technology, new business avenues and inorganic movements.

The entry of GIC marks a significant event in the company’s evolution. “This move is a milestone in our 48-year history, a result of CIMED’s reputation and growth potential,” said Marques.

Related insights

  • Banking

    Landmark deal for Brazil’s farmers in climate fight

    September 26, 2024

    J.P. Morgan recently arranged an $800 million loan for Banco do Brasil to fund more sustainable farming practices.

  • Banking

    Financing a more sustainable future for El Salvador’s Lempa River

    November 19, 2024

    J.P Morgan played an integral role in the world’s largest debt-for-nature transaction aimed at supporting river conservation.

  • Investment Banking

    Investment Banking

    Providing investment banking solutions, including mergers and acquisitions, capital raising and risk management, for a broad range of corporations, institutions and governments.

This material (including market commentary, market data, observations or the like) has been prepared by personnel in the Investment Banking Group of JPMorgan Chase & Co. It has not been reviewed, endorsed or otherwise approved by, and is not a work product of, any research department of JPMorgan Chase & Co. and/or its affiliates (“J.P. Morgan”).

Any views or opinions expressed herein are solely those of the individual authors and may differ from the views and opinions expressed by other departments or divisions of J.P. Morgan. This material is for the general information of our clients only and is a “solicitation” only as that term is used within CFTC Rule 1.71 and 23.605 promulgated under the U.S. Commodity Exchange Act.

RESTRICTED DISTRIBUTION: This material is distributed by the relevant J.P. Morgan entities that possess the necessary licenses to distribute the material in the respective countries. This material is proprietary and confidential to J.P. Morgan and is for your personal use only. Any distribution, copy, reprints and/or forward to others is strictly prohibited.

This material is intended merely to highlight market developments and is not intended to be comprehensive and does not constitute investment, legal or tax advice, nor does it constitute an offer or solicitation for the purchase or sale of any financial instrument or a recommendation for any investment product or strategy.

Information contained in this material has been obtained from sources believed to be reliable but no representation or warranty is made by J.P. Morgan as to the quality, completeness, accuracy, fitness for a particular purpose or noninfringement of such information. In no event shall J.P. Morgan be liable (whether in contract, tort, equity or otherwise) for any use by any party of, for any decision made or action taken by any party in reliance upon, or for any inaccuracies or errors in, or omissions from, the information contained herein and such information may not be relied upon by you in evaluating the merits of participating in any transaction. All information contained herein is as of the date referenced and is subject to change without notice. All market statistics are based on announced transactions. Numbers in various tables may not sum due to rounding.

J.P. Morgan may have positions (long or short), effect transactions, or make markets in securities or financial instruments mentioned herein (or options with respect thereto), or provide advice or loans to, or participate in the underwriting or restructuring of the obligations of, issuers mentioned herein. All transactions presented herein are for illustration purposes only. J.P. Morgan does not make representations or warranties as to the legal, tax, credit, or accounting treatment of any such transactions, or any other effects similar transactions may have on you or your affiliates. You should consult with your own advisors as to such matters.

The use of any third-party trademarks or brand names is for informational purposes only and does not imply an endorsement by JPMorgan Chase & Co. or that such trademark owner has authorized JPMorgan Chase & Co. to promote its products or services.

J.P. Morgan is the marketing name for the investment banking activities of JPMorgan Chase Bank, N.A., J.P. Morgan Securities LLC (member, NYSE), J.P. Morgan Securities plc (authorized by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority), J.P. Morgan SE (Authorised as a credit institution by the Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht, BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB)), J.P. Morgan Securities Australia Limited (ABN 61 003 245 234/AFS Licence No: 238066 and regulated by Australian Securities and Investments Commission) and their investment banking affiliates. J.P. Morgan Securities plc is exempt from the licensing provisions of the Financial and Intermediary Services Act, 2002 (South Africa).

For Brazil: Ombudsman J.P. Morgan: 0800-7700847 / ouvidoria.jp.morgan@jpmorgan.com

For Australia: This material is issued and distributed by J.P. Morgan Securities Australia Limited (ABN 61 003 245 234/ AFS Licence No: 238066) (regulated by ASIC) for the benefit of “wholesale clients” only. This material does not take into account the specific investment objectives, financial situation or particular needs of the recipient. The recipient of this material must not distribute it to any third party or outside Australia without the prior written consent of J.P. Morgan Securities Australia Limited.